相关实验视频

Updated: May 20, 2025

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

12.9K

运动神经元疾病中辅助通风撤回:最新的结果

Lucy Bleazard1,2, Jonathan Palmer3, David Wenzel4

  • 1Population Health Sciences, University of Leicester, Leicester, UK lucybleazard@loros.co.uk.

BMJ supportive & palliative care
|March 24, 2025
PubMed
概括

医疗保健专业人员 (HCP) 发现,针对移动神经元疾病 (MND) 患者的提取辅助通风的个性化方法是有效的. 更新的指南现在包括通风器管理建议.

关键词:
教育和培训教育和培训.在家护理 家庭护理临终关怀医院的护理.抚慰性护理是一种缓解性护理.症状和症状管理 症状和症状管理终端护理服务提供者

更多相关视频

Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties08:27

Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties

Published on: February 19, 2020

14.1K
Evaluation of Respiratory Muscle Activation Using Respiratory Motor Control Assessment RMCA in Individuals with Chronic Spinal Cord Injury09:37

Evaluation of Respiratory Muscle Activation Using Respiratory Motor Control Assessment RMCA in Individuals with Chronic Spinal Cord Injury

Published on: July 19, 2013

10.2K

相关概念视频

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
581
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K